Alume Biosciences Inc — Form D/A

Alume Biosciences Inc of LA JOLLA, CA, a company, filed a Form D amendment with the SEC on 2025-12-31. The offering totals $23.5M, of which $5.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (28)

Showing 25 of 28 people.

NameRoleLocation
Brett BermanDirectorLa Jolla, CA
Dan BradburyDirectorLa Jolla, CA
Kim KamdarDirectorSan Diego, CA
Magda MarquetDirectorLa Jolla, CA
Jean-Pierre MillonDirectorLa Jolla, CA
Quyen NguyenDirectorLa Jolla, CA
Brett BermanExecutive OfficerLa Jolla, CA
Quyen NguyenExecutive OfficerLa Jolla, CA
Kaveri ParkerExecutive OfficerLa Jolla, CA
James SchmidtExecutive OfficerLa Jolla, CA
Kaveri ParkerRelated PersonLa Jolla, CA
Magda MarquetRelated PersonLa Jolla, CA
Kim KamdarRelated PersonSan Diego, CA
Brett BermanRelated PersonLa Jolla, CA
James SchmidtRelated PersonLa Jolla, CA
Jean-Pierre MillonRelated PersonLa Jolla, CA
Quyen NguyenRelated PersonLa Jolla, CA
Dan BradburyRelated PersonLa Jolla, CA
Jean-Pierre T MillonDirectorSan Diego, CA
Kim T KamdarDirectorSan Diego, CA
Magda T MarquetDirectorSan Diego, CA
Brett T BermanDirectorSan Diego, CA
Brett T BermanExecutive OfficerSan Diego, CA
James T SchmidtExecutive OfficerSan Diego, CA
Dan T BradburyDirectorSan Diego, CA

Other filings by this issuer (11)

FiledFormOfferingSold
2026-05-08D/A$8.0M$2.2M
2026-04-06D$8.0M$110K
2026-02-19D/A$23.5M$6.9M
2026-01-30D/A$23.5M$6.0M
2025-11-12D/A$23.5M$3.6M
2025-10-31D$23.5M$3.1M
2023-01-09D$45.0M$12.8M
2022-09-21D/A$5.2M$4.0M
2022-04-15D$5.0M$3.0M
2020-08-26D$4.0M$4.0M
2019-07-11D$8.6M$5.8M

More